← Evidence map

ArticleBMC cancer2021

High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer.

Takuya Shiraishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33757462